Generic Drugmaker Tells High Court To Block Purdue’s Oxycontin Patent Petition
WASHINGTON, D.C. — The U.S. Supreme Court should reject a petition for a writ of certiorari from Purdue Pharma LP and related entities, a generic drug manufacturer told the high court...To view the full article, register now.
Already a subscriber? Click here to view full article